iOnctura’s roginolisib awarded Innovation Passport
MHRA designation involves entry into innovative licensing and access pathway
Read More
Tag: roginolisib
iOnctura reveals roginolisib research results
Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
